1254. Deputy John Paul Phelan asked the Minister for Health when Ireland intends to align with the NICE recommendations on CGM for certain eligible cohorts of insulin-using individuals with type 2 diabetes (details supplied); and if he will make a statement on the matter. [45138/24]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medical products; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.